Computational Biology Consulting

Turning omics data into
drug discovery insights

Two decades in computational biology, eight of them in pharma — now building AI tools that turn data and knowledge into evidence-grounded insights, so teams make drug-discovery decisions faster.

Human geneticsTarget identificationIndication expansionBiomarker discoveryBiomarker panel designPatient stratification
CardiovascularFibrosisImmunologyNeuroscience

Across the pipeline and in both directions — from discovery to the clinic, and back. For teams from preclinical biotechs to large pharma.

Multi-Omics Analysis

RNA-seq, single-cell, spatial transcriptomics, proteomics — integrated analyses that connect molecular signals to biology.

AI for Data Analysis

Practical LLM tooling for biomedical data analysis — literature mining, evidence extraction, and analytical code review.

Pharma-Ready

Deep experience at Bristol Myers Squibb, Jackson Laboratory, and Princeton University.

Where the work has been

From target nomination to biomarker discovery to single-cell analysis — hands-on experience across the drug discovery pipeline.

Bristol Myers SquibbThe Jackson LaboratoryPrinceton UniversityCarnegie Mellon University

Ready to accelerate your research?

Let's discuss how TensorOmics can support your next project.

Get in Touch